Explained: which drugs has Donald Trump been prescribed and why?
Experts say cocktail of medication suggests the president may be seriously ill with Covid
The coronavirus drugs prescribed to Donald Trump indicate that the president may be battling a more severe case of Covid-19 than the White House is letting on, according to infectious disease experts.
After testing positive for coronavirus last week, Trump has been given a powerful cocktail of medications including antiviral drug remdesivir, a steroid called dexamethasone and a combination of antibodies. The 74-year-old’s doctors say he is also taking zinc, vitamin D, famotidine, melatonin and aspirin, but “it is not clear if any of these are deliberately for Covid 19”, the BBC reports.
The combination of drugs given to the president “may never have been prescribed together to an individual patient”, adds the Financial Times. Indeed, the breadth of medicines being taken by Trump has led some experts to suggest that the US leader may be more unwell than his lead physician, Sean Conley, has admitted.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Some experts have raised another possibility: that Trump is directing his own treatment, and is demanding drugs that he does not fully understand.
This phenomenon, says the The New York Times, even has a name: “VIP syndrome, which describes prominent figures who receive poor medical care because doctors are too zealous in treating them - or defer too readily to their instructions”.
“You think you’re helping,” Dr Celine Gounder, a clinical assistant professor of medicine and infectious diseases at the NYU Grossman School of Medicine, told the newspaper. “But this is really a data-free zone, and you just don’t know that.”
Either way, “the use of the experimental treatments will have required a careful weighing of the risks, given the possible side-effects and the chance of adverse interactions between the different chemicals”, says the FT.
Dexamethasone
This steroid works by calming the immune system, but a British professor who led the trial of the drug has said that it works best on serious cases of Covid-19 - “adding to fears over the seriousness of the president’s illness”, The Telegraph reports.
“Dexamethasone reduces mortality or improves survival particularly for patients with severe Covid,” Martin Landray, a professor of medicine and epidemiology at the University of Oxford, told the paper.
Monoclonal antibody therapy
Made by US biotechnology company Regeneron, this combination of antibodies mimics the natural human immune response. There is “huge hope it will be effective”, says the BBC, but “the evidence in patients is still very limited and these monoclonals are still classed as an experimental drug”.
“The president is one of only a handful of people outside those trials to undergo the treatment under what is known as ‘compassionate use’,” the broadcaster adds.
Remdesivir
Developed originally as a treatment for Ebola, remdesivir works by disrupting the ability of the virus to copy itself. Clinical trials have shown the drug can cut the duration of Covid symptoms from 15 days to 11, but it is not a life-saving drug.
And the rest
Vitamin D and zinc both have a role in a healthy immune system, but have never been proven to help fight Covid.
Famotidine decreases stomach acid production and is used for people with stomach ulcers or reflux. Meanwhile, melatonin is a hormone that can improve sleep, while aspirin is a pain killer and blood thinner.
Trials to determine whether aspirin could help fight coronavirus have been launched, but no evidence supporting that hope has emerged.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Arion McNicoll is a freelance writer at The Week Digital and was previously the UK website’s editor. He has also held senior editorial roles at CNN, The Times and The Sunday Times. Along with his writing work, he co-hosts “Today in History with The Retrospectors”, Rethink Audio’s flagship daily podcast, and is a regular panellist (and occasional stand-in host) on “The Week Unwrapped”. He is also a judge for The Publisher Podcast Awards.
-
'It may not be surprising that creative work is used without permission'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
5 simple items to help make your airplane seat more comfortable
The Week Recommends Gel cushions and inflatable travel pillows make a world of difference
By Catherine Garcia, The Week US Published
-
How safe are cruise ships in storms?
The Explainer The vessels are always prepared
By Devika Rao, The Week US Published
-
'It may not be surprising that creative work is used without permission'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
What message is Trump sending with his Cabinet picks?
TODAY'S BIG QUESTION By nominating high-profile loyalists like Matt Gaetz and RFK Jr., is Trump serious about creating a functioning Cabinet, or does he have a different plan in mind?
By Rafi Schwartz, The Week US Published
-
Gaetz ethics report in limbo as sex allegations emerge
Speed Read A lawyer representing two women alleges that Matt Gaetz paid them for sex, and one witnessed him having sex with minor
By Peter Weber, The Week US Published
-
The clown car cabinet
Opinion Even 'Little Marco' towers above his fellow nominees
By Mark Gimein Published
-
What Mike Huckabee means for US-Israel relations
In the Spotlight Some observers are worried that the conservative evangelical minister could be a destabilizing influence on an already volatile region
By Rafi Schwartz, The Week US Published
-
The Pentagon faces an uncertain future with Trump
Talking Point The president-elect has nominated conservative commentator Pete Hegseth to lead the Defense Department
By Justin Klawans, The Week US Published
-
'All Tyson-Paul promised was spectacle and, in the end, that's all we got'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Can Europe pick up the slack in Ukraine?
Today's Big Question Trump's election raises questions about what's next in the war
By Joel Mathis, The Week US Published